Medical Research · PA
Nrg Oncology Foundation Inc
Nrg Oncology Foundation Inc reported paying Sharon Hartson Stine, Interim Executive Director, $14,948 in total compensation (FY 2023).
That places Sharon Hartson Stine at approximately the 4th percentile among 28 similarly sized medical research nonprofits (median $494,350).
$32,205,558Total revenue (FY 2023)
$14,948Total executive compensation
4thPercentile vs. peers
Setting executive pay for this board?
Generate a board-ready comparability report for Nrg Oncology Foundation Inc — named comparables, percentiles, methodology, and the 26 CFR 53.4958-6 minutes language a board can use toward the rebuttable presumption.
Build the comparability report →Comparable medical research nonprofits
Compensation is normalized to PA cost of living (BEA Regional Price Parities); each organization's reported figure is on its linked 990.
| Organization | State | Revenue | Total comp |
|---|---|---|---|
| Wills Eye Ophthalmology | PA | $31,970,742 | $256,175 |
| Greenwood Genetic Center Inc | SC | $31,727,683 | $437,761 |
| Max Planck Florida Corporation | FL | $33,505,675 | $497,742 |
| Palo Alto Veterans Institute For | CA | $30,503,398 | $263,344 |
| New York Stem Cell Foundation Inc | NY | $30,392,844 | $573,894 |
| Transcelerate Biopharma Inc | PA | $34,168,812 | $2,534,948 |
| Centre County Cancer Center | PA | $29,580,970 | $183,784 |
| American Urological Association | MD | $35,355,221 | $599,411 |